[1. Gaebel W, Riesbeck M, Wobrock T. Schizophrenia guidelines across the world: a selective review and comparison. Int Rev Psychiatry 2011; 23(4): 379-87.10.3109/09540261.2011.60680122026495]Search in Google Scholar
[2. Hasan A, Wobrock T, Gaebel W, Janssen B, Zielasek J, Falkai P. National and international schizophrenia guidelines. Update 2013 regarding recommendations about antipsychotic pharmacotherapy]. Nervenarzt 2013; 84(11): 1359-60,1362-4, 1366-8.10.1007/s00115-013-3913-624077969]Search in Google Scholar
[3. Janssen B, Ludwig S, Eustermann H, Menke R, Haerter M, Berger M, Adam G, Seemann U, Kissling W, Gaebel W. Improving outpatient treatment in schizophrenia: effects of computerized guideline implementation-- results of a multicenter-study within the German research network on schizophrenia. Eur Arch Psychiatry Clin Neurosci 2010; 260(1): 51-7.10.1007/s00406-009-0016-219876665]Search in Google Scholar
[4. Busch AB, Lehman AF, Goldman H, Frank RG. Changes over time and disparities inschizophrenia treatment quality. Med Care 2009; 47(2): 199-207.10.1097/MLR.0b013e31818475b7278976619169121]Search in Google Scholar
[5. Barbui C, Girlanda F, Ay E, Cipriani A, Becker T, Koesters M. Implementation of treatment guidelines for specialist mental health care. Cochrane Database Syst Rev 2014; 1: CD009780.10.1002/14651858.CD009780.pub224443146]Search in Google Scholar
[6. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282(15): 1458-65.10.1001/jama.282.15.145810535437]Search in Google Scholar
[7. Godlee F, Pakenham-Walsh N, Ncayiyana D, Cohen B, Packer A. Can we achieve health information for all by 2015? Lancet 2004; 364(9430): 295-300.]Search in Google Scholar
[8. Larme AC, Pugh JA. Evidence-based guidelines meet the real world: the case of diabetes care. Diabetes Care 2001; 24(10): 1728-33.10.2337/diacare.24.10.172811574433]Search in Google Scholar
[9. Stevović-Injac L, Đedović J, Tomčuk A. Shizofrenija - Nacionalne smjernice dobre kliničke prakse. Ministarstvo zdravlja, Radna grupa za izradu i implementaciju kliničkih protokola i smjernica i razvoj sistema osiguranja kvaliteta, Podgorica, 2012.]Search in Google Scholar
[10. Higashi K, Medic G, Littlewood KJ, Diez T, Granstrom O, De Hert M. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol 2013; 3(4): 200-18.10.1177/2045125312474019380543224167693]Search in Google Scholar
[11. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK; Clinical Antipsychotic Trials of Intervention effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353(12): 1209-23.10.1056/NEJMoa05168816172203]Search in Google Scholar
[12. De las Cuevas C, Rivero-Santana A, Perestelo-Perez L, Perez-Ramos J, Serrano-Aguilar P. Attitudes toward concordance in psychiatry: a comparative, cross-sectional study of psychiatric patients and mental health professionals. BMC Psychiatry 2012; 12: 53.10.1186/1471-244X-12-53340384822646974]Search in Google Scholar
[13. Addington D, McKenzie E, Smith H, Chuang H, Boucher S, Adams B, Ismail Z. Conformance to evidence- based treatment recommendations in schizophrenia treatment services. Can J Psychiatry 2012; 57(5): 317-23.10.1177/07067437120570050722546064]Search in Google Scholar